Dr. Reddy’s Laboratories Ltd has launched Levocetirizine Dihydrochloride tablets, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy 24HR tablets, in the US market. Xyzal is a registered trademark of the UCB group of companies.
Levocetirizine Dihydrochloride tablets are an over-the-counter antihistamine used for 24-hour relief from allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. "This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” Milan Kalawadia, Vice-President and Head, US Over-the-Counter and Speciality Rx businesses, Dr. Reddy’s Laboratories, said in a release issued here on Friday.
``We look forward to collaborating with our customers to bring high-quality, affordable store brand alternatives to the market.” The Xyzal Allergy 24HR tablets brand had US sales of approximately $71 million for the most recent 12 months ending in January 2018, according to IRI. Dr. Reddy’s Levocetirizine Dihydrochloride Tablets USP is available in 5 mg strength and in various consumer-oriented package sizes.